Home › Expected Toxicity of Claimed Immunoconjugates Thwarts Showing of...
 

Keywords :   


Expected Toxicity of Claimed Immunoconjugates Thwarts Showing of...

2016-03-09 05:27:50| Biotech - Topix.net

Expected Toxicity of Claimed Immunoconjugates Thwarts Showing of Prima Facie Obviousness ) In an inter partes review proceeding, the Patent Trial and Appeal Board upheld the patentability of Phigenix's patent claims that were challenged on the basis of obviousness. Phigenix, Inc. v.

Tags: of showing expected claimed

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
17.05Reddit shares jump after OpenAI ChatGPT deal
17.05Is China's bubble tea bubble about to burst?
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
17.05Business locked in expensive AI 'arms race'
17.05Is the move to electric cars running out of power?
More »